Improved efficacy/safety profile of factor XIa inhibitor BMS-724296 versus factor Xa inhibitor apixaban and thrombin inhibitor dabigatran in cynomolgus monkeys.

Research and Practice in Thrombosis and Haemostasis
Pancras C Wong, Mimi L Quan

Abstract

Inhibition of activated factor XI (FXIa) is a promising antithrombotic drug target. BMS-724296 is a selective, reversible, small-molecule inhibitor of human FXIa (Ki 0.3 nM). This study assessed effects of BMS-724296 versus standard-of-care oral anticoagulants apixaban (activated factor X inhibitor) and dabigatran (thrombin inhibitor) on arterial thrombosis, kidney bleeding time (KBT), and clotting time (CT) in nonhuman primate (NHP) cynomolgus monkey models. Carotid artery thrombosis was produced by electrical stimulation in anesthetized NHPs. Hemostasis was assessed with a provoked KBT model. Thrombosis, KBT, and CT were monitored. Vehicle and various doses of BMS-724296, apixaban, and dabigatran were administered as bolus (intravenous [i.v.]) followed by infusion starting 30 minutes before initiation of thrombosis and continued until the experiment's end (n = 3-8/group). Primary end points included thrombus weight reduction (TWR), KBT, and CT (activated partial thromboplastin time [aPTT], prothrombin time [PT], and thrombin time [TT]). BMS-724296 at 0.025 + 0.05, 0.05 + 0.1, 0.102 + 0.2, and 0.4 + 0.8 mg/kg+mg/kg/h i.v. (bolus + infusion) reduced thrombus weight by 0 ± 0, 35 ± 7*, 72 ± 4*, and 86 ± 4%*, respectively (*P < .0...Continue Reading

References

Oct 10, 2002·Bioorganic & Medicinal Chemistry Letters·James C SuttonGregory S Bisacchi
Jan 5, 2005·Seminars in Thrombosis and Hemostasis·Jeanine M Walenga, Debra A Hoppensteadt
Jun 29, 2007·European Journal of Pharmacology·William A SchumacherMartin L Ogletree
Jan 30, 2010·Blood·Jonas EmsleyDavid Gailani
Feb 9, 2010·Arteriosclerosis, Thrombosis, and Vascular Biology·William A SchumacherDietmar A Seiffert
Mar 13, 2010·Journal of Cardiovascular Pharmacology·William A SchumacherPancras C Wong
May 27, 2011·Journal of Thrombosis and Thrombolysis·Pancras C WongWilliam A Schumacher
Aug 23, 2012·Xenotransplantation·Hayato IwaseMohamed B Ezzelarab
Jan 11, 2014·Journal of Medicinal Chemistry·Mimi L QuanRuth R Wexler
Dec 9, 2014·The New England Journal of Medicine·Harry R BüllerUNKNOWN FXI-ASO TKA Investigators
Dec 15, 2015·Journal of Thrombosis and Thrombolysis·Pancras C WongEarl J Crain
May 14, 2016·Arteriosclerosis, Thrombosis, and Vascular Biology·David Gailani, Andras Gruber
Nov 24, 2017·Stroke; a Journal of Cerebral Circulation·Marco ProiettiGregory Y H Lip
Dec 23, 2017·Arteriosclerosis, Thrombosis, and Vascular Biology·Jeffrey I Weitz, James C Fredenburgh
May 19, 2018·Journal of Medicinal Chemistry·Mimi L QuanRuth R Wexler
Jun 30, 2019·TH Open : Companion Journal to Thrombosis and Haemostasis·Paul Y KimJeffrey I Weitz
Jan 15, 2020·JAMA : the Journal of the American Medical Association·Jeffrey I WeitzGary E Raskob
Jun 17, 2020·Journal of the American Heart Association·Ashley ChenBruce A Warden

❮ Previous
Next ❯

Software Mentioned

GraphPad
Prism
KBT
ECAT

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.